Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Pfizer Rallies Off Q1 Report
Mid-Afternoon Market Update: On Deck Capital Drops Following Earnings Miss; Symmetry Surgical Shares Spike Higher
Stocks Deep In Red, But Apple, Pfizer Defy Sell-Off (Investor's Business Daily)
Related LNKD
Avondale Lifts LinkedIn's Target To $140, Though Some Slower Expectations Exist
Wide Moat ETF Is On A Tear
LinkedIn: Can Results Justify The Stock Price? (Seeking Alpha)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
May 2016Leerink SwannMaintainsMarket Perform
Apr 2016Goldman SachsReinstatesNeutral
Apr 2016JP MorganAssumesOverweight

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

View Comments and Join the Discussion!